Skip to main content

Hydrodissection

Hydrodissection — submucosal injection of fluid into the vaginal wall to hydraulically separate the vaginal epithelium from the underlying fibromuscular layer — is considered the standard of care in vaginal prolapse surgery.[1][2] It serves two purposes at once: it creates a defined dissection plane (between the epithelium and the pubocervical connective tissue anteriorly / rectovaginal septum posteriorly), and, when a vasoconstrictor is added, it provides tamponade and vasoconstriction that reduce intraoperative blood loss. A Cochrane review confirms saline hydrodissection significantly reduces intraoperative blood loss versus dissection without infiltration.[1]

This page covers both halves of the topic the bedside decision actually involves: the agent (what to put in the syringe) and the technique (where and how to inject it).

Principle and Purpose​

The injected fluid balloons the submucosa and visually delineates the cleavage plane, so dissection follows hydraulics rather than blind sharp cutting. Adding a vasoconstrictor compresses and constricts the submucosal vessels along that plane. The two goals are partly independent: plain saline already separates the plane and reduces bleeding; the vasoconstrictor adds incremental hemostasis at the cost of a (usually small) systemic exposure.[1][2]

Technique by Procedure​

Anterior colporrhaphy​

After an Allis clamp is placed on the anterior vaginal wall, solution is injected submucosally along the planned incision and laterally into the vesicovaginal space until the tissue balloons and the plane between epithelium and pubocervical connective tissue is visible. A midline vertical incision is carried through the distended epithelium, then sharp/blunt dissection proceeds laterally to the arcus tendineus fascia pelvis.[2][3] A randomized trial (46 patients) found hydrodissection produced significantly less bleeding (ΔHb 0.66 vs 1.21 g/dL, p = 0.05) without degrading the plane — histology showed no difference in connective tissue left at the surgical margin.[2]

Posterior colporrhaphy​

The same maneuver: submucosal injection along the posterior wall before the sagittal colpotomy, then full-thickness dissection of the posterior wall from the incision toward the apex, opening the pararectal spaces laterally toward the sacrospinous ligament.[3]

Vaginal hysterectomy​

A pericervical / intracervical circumferential injection before the initial circumferential incision distends the vesicovaginal and rectovaginal planes and eases entry into the anterior and posterior cul-de-sacs. A meta-analysis of 7 RCTs (455 patients) found vasopressin-based hydrodissection cut estimated blood loss by a mean of 119.85 mL (95% CI −177.55 to −62.14); an RCT of cervical vasopressin reduced blood loss to ~145 vs 266 mL (p = 0.022).[7][8]

Colpocleisis (LeFort and total)​

Hydrodissection — commonly with lidocaine and epinephrine — precedes excision of the rectangular epithelial patches, lifting the epithelium off the muscularis to give clean planes for the subsequent purse-string plication.[4][5]

Vaginal mesh procedures​

Hydrodissection with normal saline is performed before the vaginal-wall incision in transobturator/transgluteal and single-incision systems; the vesicovaginal dissection is then carried laterally to the arcus tendineus fascia pelvis.[3]

Injectate Agents and Dilutions​

AgentTypical dilution / doseEffect on blood lossKey consideration
Normal saline alone20–60 mL typicalSignificant vs no infiltrationBaseline; plane separation without vasoconstriction[1][2]
Saline + epinephrine1:200,000 (5 µg/mL)Enhanced vs saline aloneMost widely used; standard in many centers[10]
Ornipressin (Por-8)5 IU in 100 mL saline (0.05 IU/mL); ~80 mL/compartmentMedian 35 vs 81 mL saline (p = 0.03)No significant CV effects; not available in US[6]
Vasopressin4–20 units in 20–100 mL saline (≤0.2 U/mL)~120 mL reduction (vaginal hyst)Rare but serious CV events — inject with caution[7][12]
Lidocaine + epinephrineStandard local-anesthetic concentrationsAnalgesia + vasoconstrictionPreferred for colpocleisis; LAST risk at high volume[4]

A meta-analysis of 9 RCTs (903 participants) found vasoconstrictive agents (vasopressin/ornipressin) reduced blood loss by an overall ~70 mL (95% CI −125 to −14) versus placebo/saline, with substantial heterogeneity in dose and technique.[11]

Vasopressin​

The most studied agent, given by intracervical/pericervical injection. A meta-analysis (7 RCTs, 455 patients) showed a mean blood-loss reduction of 119.85 mL; a double-blind RCT (117 women) confirmed lower EBL (312 vs 446 mL, p = 0.006) and a smaller hemoglobin drop with no increase in pelvic infection (1.6% vs 7.3%).[7][9] It carries the most evidence — and the most cardiovascular risk (below).

Ornipressin (Por-8)​

A synthetic vasopressin analogue with a more selective V1 profile. The only dedicated vaginal-prolapse RCT (80 women, 5 IU/100 mL, 80 mL per compartment) cut median blood loss from 81 to 35 mL (p = 0.03) with no significant change in blood pressure or pulse — the favorable cardiovascular profile is its distinguishing feature, offset by limited availability (not marketed in the US).[6]

Epinephrine (adrenaline)​

The most universally available additive, typically 1:200,000. No RCT has compared epinephrine to placebo specifically in vaginal prolapse or vaginal hysterectomy; the best comparative data are from myomectomy, where dilute vasopressin and dilute epinephrine produced no difference in blood loss, with transient BP/HR rises only in the epinephrine arm.[10] As a general infiltration caution, avoid epinephrine in end-artery fields — the penis, digits, and the penile-prosthesis field.

Head-to-head summary​

VasopressinOrnipressinEpinephrine 1:200,000
CV safetyTransient BP rise; rare cardiac arrestNo significant BP/HR changeTransient BP/HR rise; well tolerated
Serious AEsBradycardia, cardiac arrest (case reports)None in RCT dataRare at standard dilution
AvailabilityWide (some countries restrict)Not in USUniversal
Evidence in vaginal surgeryMultiple RCTs + 2 meta-analysesSingle RCT (n=80)No vaginal-surgery RCT

Where available, ornipressin offers the best safety-to-efficacy ratio (limited to one trial); vasopressin has the strongest evidence base but demands dosing and monitoring discipline; epinephrine is the default by availability and familiarity.[6][7][11]

Cardiovascular Safety — Vasopressin​

The dominant safety concern is vasopressin. Serious events — bradycardia, myocardial ischemia, and cardiac arrest — have been reported even at low concentrations, with cardiac arrest occurring within ~2 minutes of injection, thought to follow inadvertent intravascular injection or rapid absorption; laparoscopic/robotic cases under pneumoperitoneum appear higher-risk.[12][13][14] Practical precautions:[12][15]

  • Aspirate before injecting to avoid an intravascular bolus.
  • Use the lowest effective concentration (≤0.2 U/mL) and limit total dose (most RCTs used 4–20 units).
  • Tell the anesthesia team before injecting; have atropine and resuscitation equipment ready.
  • Extra caution with cardiovascular/coronary disease. ACOG recommends cautious administration of vasoconstrictors given the rare-but-serious risk.[15]

Does Hydrodissection Harm the Repair Plane?​

A recurring worry is that ballooning the submucosa "floats" the fibromuscular layer ("pubocervical fascia," not a true anatomic fascia) off where the surgeon needs it. The Schwarzman RCT answers it directly: loose connective tissue at the surgical margin was no different with vs without hydrodissection (13.6% vs 27.3%, p = 0.46) — hydrodissection does not compromise plane integrity.[2] The practical caveat is volume: over-injection, especially in atrophic postmenopausal tissue, can distort planes and make the correct layer harder to find.

Adjacent Considerations​

  • Vaginal microcirculation — incident dark-field imaging shows measurable microvascular change after prolapse surgery (performed with saline + 1:200,000 adrenaline), a tool for studying postoperative vascular damage relevant to mesh erosion and recurrence.[16]
  • Practice variation — a Dutch survey of 133 gynecologists found wide variation in whether and how hydrodissection is used during anterior colporrhaphy, underscoring that "standard of care" has not produced a standardized technique.[17]

Practical Pearls​

  • Saline alone is legitimate — it separates the plane and reduces bleeding; the vasoconstrictor is an additive decision, not a requirement.[1]
  • Aspirate, low concentration, talk to anesthesia whenever vasopressin is used.[12]
  • Inject to balloon, not to flood — enough to define the plane; excess distorts it, worst in atrophic tissue.
  • Match agent to procedure — lidocaine + epinephrine for colpocleisis (analgesia + hemostasis); saline ± epinephrine for colporrhaphy and mesh; vasopressin/ornipressin where pericervical blood loss at vaginal hysterectomy is the concern.

See Also​

References​

1. Shahid U, Haya N, Baessler K, et al. Perioperative interventions in pelvic organ prolapse surgery. Cochrane Database Syst Rev. 2025;7:CD013105. doi:10.1002/14651858.CD013105.pub2

2. Schwarzman P, Samueli B, Shaco-Levy R, et al. The role of hydrodissection in native tissue repair of anterior vaginal wall defects. Aust N Z J Obstet Gynaecol. 2022;62(1):98–103. doi:10.1111/ajo.13431

3. Campagna G, Panico G, Morciano A, et al. Vaginal mesh repair systems for pelvic organ prolapse: anatomical study comparing transobturator/transgluteal versus single-incision techniques. Neurourol Urodyn. 2018;37(3):1024–1030. doi:10.1002/nau.23387

4. Raju R, Occhino JA, Linder BJ. LeFort partial colpocleisis: tips and technique. Int Urogynecol J. 2020;31(8):1697–1699. doi:10.1007/s00192-019-04194-3

5. Linder BJ, Gebhart JB, Occhino JA. Total colpocleisis: technical considerations. Int Urogynecol J. 2016;27(11):1767–1769. doi:10.1007/s00192-016-3034-4

6. Henn EW, Nondabula T, Juul L. Effect of vaginal infiltration with ornipressin or saline on intraoperative blood loss during vaginal prolapse surgery: a randomised controlled trial. Int Urogynecol J. 2016;27(3):407–412. doi:10.1007/s00192-015-2821-7

7. Hafidh B, Latifah HM, Gari A, et al. Vasopressin to control blood loss during hysterectomy: a systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol. 2022;29(3):355–364.e2. doi:10.1016/j.jmig.2021.10.003

8. Ascher-Walsh CJ, Capes T, Smith J, Michels A. Cervical vasopressin compared with no premedication and blood loss during vaginal hysterectomy: a randomized controlled trial. Obstet Gynecol. 2009;113(2 Pt 1):313–318. doi:10.1097/AOG.0b013e3181954c44

9. Kammerer-Doak DN, Rogers RG, Johnson Maybach J, Traynor Mickelson M. Vasopressin as an etiologic factor for infection in gynecologic surgery: a randomized double-blind placebo-controlled trial. Am J Obstet Gynecol. 2001;185(6):1344–1347. doi:10.1067/mob.2001.119076

10. Song T, Kim MK, Kim ML, et al. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;195:177–181. doi:10.1016/j.ejogrb.2015.10.003

11. Cui Y, Chen I, Chernoff A, Clancy A. Effectiveness of prophylactic pharmacological hemostatic agents for reduction of blood loss at vaginal surgery: a systematic review and meta-analysis. Int Urogynecol J. 2023;34(12):2945–2957. doi:10.1007/s00192-023-05614-1

12. Chudnoff S, Glazer S, Levie M. Review of vasopressin use in gynecologic surgery. J Minim Invasive Gynecol. 2012;19(4):422–433. doi:10.1016/j.jmig.2012.03.022

13. Lee GG, Baek SY, Woo Kim T, et al. Cardiac arrest caused by intramyometrial injection of vasopressin during a robotic-assisted laparoscopic myomectomy. J Int Med Res. 2018;46(12):5303–5308. doi:10.1177/0300060518805596

14. Hobo R, Netsu S, Koyasu Y, Tsutsumi O. Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol. 2009;113(2 Pt 2):484–486. doi:10.1097/AOG.0b013e318187e795

15. Committee on Gynecologic Practice. The use of hysteroscopy for the diagnosis and treatment of intrauterine pathology: ACOG Committee Opinion No. 800. Obstet Gynecol. 2020;135(3):e138–e148. doi:10.1097/AOG.0000000000003712

16. Kastelein AW, Diedrich CM, de Waal L, Ince C, Roovers JWR. The vaginal microcirculation after prolapse surgery. Neurourol Urodyn. 2020;39(1):331–338. doi:10.1002/nau.24203

17. Lensen EJ, Stoutjesdijk JA, Withagen MI, Kluivers KB, Vierhout ME. Technique of anterior colporrhaphy: a Dutch evaluation. Int Urogynecol J. 2011;22(5):557–561. doi:10.1007/s00192-010-1353-4